Clinical Trial Update: Medtronic Reveal XT Study [Phase 2]

View source ↗

Summary

Phase 2 results for the Medtronic Reveal XT study in atrial fibrillation have been completed and posted on 2017-08-03.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Washington University School of Medicine | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2017-08-03